Cargando…

CBMS-12 Pro renin receptor antibody regulates glioblastoma stemness

Objective: Glioblastoma multiforme (GBM) is characterized by a strong self-renewal potential and poor differentiated state. We previously reported that (pro)renin receptor (PRR) was a potential target for glioma therapy by silencing the gene of PRR. Here, we have developed the monoclonal antibody of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimori, Takeshi, Oagawa, Daisuke, Kanda, Takahiro, Suzuki, Kenta, Shibayama, Saki, Miyake, Keisuke, Nishiyama, Akira, Tamiya, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699080/ http://dx.doi.org/10.1093/noajnl/vdaa143.019

Ejemplares similares

ET-04 MOLECULAR TARGETED THERAPY AGAINST (PRO)RENIN RECEPTOR FOR GLIOBLASTOMA
por: Fujimori, Takeshi, et al.
Publicado: (2019)

Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis
por: Fujimori, Takeshi, et al.
Publicado: (2023)

GEN-09 Pursuing the function of microRNA targeting (Pro)renin receptor against glioma
por: Ogawa, Daisuke, et al.
Publicado: (2020)

Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma
por: Suzuki, Kenta, et al.
Publicado: (2023)

CBMS-09 Intercellular communication at glioblastoma stem cell niches
por: Hide, Takuichiro, et al.
Publicado: (2020)

BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)

NI-08 Utility of multiple positron emission tomography tracers in the diagnosis of brain tumors according to the 2016 World Health Organization classification
por: Miyake, Keisuke, et al.
Publicado: (2020)

CBMS-01 Mechanism of brain tumor malignancy caused by aging and social isolation
por: Yamashita, Daisuke, et al.
Publicado: (2020)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

CBMS-02 CROSSTALK WITH ASTROCYTES ESTABLISHES TUMOR EDGE IN GLIOBLASTOMA
por: Yamashita, Daisuke, et al.
Publicado: (2019)

CBMS-05 Biological and Pathological meaning of aneuploidy in mouse glioma stem sell
por: Negoto, Tetsuya, et al.
Publicado: (2020)

(Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma
por: Shibayama, Yuki, et al.
Publicado: (2015)

CBMS-04 Novel xenograft model to clarify tumor progressive mechanism and therapeutic target in primary central nervous system lymphoma
por: Tateishi, Kensuke, et al.
Publicado: (2020)

CBMS-01 AGE-DEPENDENT GLIOBLASTOMA PROGRESSION SUPPRESSED BY NAD+
por: Yamashita, Daisuke, et al.
Publicado: (2019)

CBMS-5 One-carbon metabolism protect glioma cells under glutamine starvation through upregulation of MTHFD2
por: Tanaka, Kazuhiro, et al.
Publicado: (2021)

CBMS-11 PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT CNS NON-GERMINOMATOUS GERM CELL TUMORS
por: Tomiyama, Arata, et al.
Publicado: (2020)

STMO-15 OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY
por: Miyake, Keisuke, et al.
Publicado: (2019)

STMO-5 Utilization of intraoperative multimodal technologies [PET and 5-ALA] for treating glioblastoma
por: Miyake, Keisuke, et al.
Publicado: (2021)

CBMS-10 Methionine metabolism closely related with self-renew, pluripotency and cell death in GICs through modification of cholesterol biosynthesis and ribosomal RNA
por: Yokogami, Kiyotaka, et al.
Publicado: (2021)

CBMS Conference
por: Lawson, H Blaine
Publicado: (1985)

CBMS-3 Potent bystander effect in suicide gene therapy using genetically engineered stem cells from human exfoliated deciduous teeth
por: Horikawa, Makoto, et al.
Publicado: (2021)

CBMS-7 IGF1/N-cadherin/Clusterin signaling axis mediates adaptive radioresistance of glioma stem cells
por: Osuka, Satoru, et al.
Publicado: (2021)

CBMS-02 Phosphoglycerate mutase 1 (PGAM1) controls DNA damage repair via regulation of WIP1 activity
por: Ohba, Shigeo, et al.
Publicado: (2020)

Glioblastoma Treatment in the Elderly
por: OKADA, Masaki, et al.
Publicado: (2017)

CBMS-3 SEARCH FOR COMPOUNDS WITH ANTI-TUMOUR EFFECTS AGAINST GLIOBLASTOMA
por: Iwashimizu, Sonoka, et al.
Publicado: (2022)

NSF-CBMS Conference
por: Chao, Jia-Arng, et al.
Publicado: (1982)

Carbohydrate-binding modules (CBMs) revisited: reduced amount of water counterbalances the need for CBMs
por: Várnai, Anikó, et al.
Publicado: (2013)

NSF-CBMS Regional Conference
por: Holmes, Mark, et al.
Publicado: (1981)

COT-11 Relationship between preoperative liquid biopsy and prognosis of glioblastoma -Next Generation Sequencing of small noncoding RNA-
por: Onishi, Shumpei, et al.
Publicado: (2021)

CBMS-NSF Conference on Wavelets and their Applications
por: Daubechies, I
Publicado: (1990)

CBMS Conference on Branching in the Presence of Symmetry
por: Sattinger, David H
Publicado: (1983)

(Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations
por: Wang, Juan, et al.
Publicado: (2018)

Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions
por: Flack, John M., et al.
Publicado: (2007)

Aberrant (pro)renin receptor expression induces genomic instability in pancreatic ductal adenocarcinoma through upregulation of SMARCA5/SNF2H
por: Shibayama, Yuki, et al.
Publicado: (2020)

CBMS-1 TARGETING GLUTAMINE METABOLISM IN IDH-MUTANT GLIOMAS
por: Ohba, Shigeo, et al.
Publicado: (2022)

IMG-02. USEFUL DIAGNOSIS OF PEDIATRIC CYSTIC BRAIN TUMORS USING MULTIPLE POSITRON EMISSION TOMOGRAPHY STUDIES
por: Miyake, Keisuke, et al.
Publicado: (2020)

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
por: Miyake, Keisuke, et al.
Publicado: (2020)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
por: Suzuki, Kenta, et al.
Publicado: (2021)

NSF/CBMS Regional Conference on Robust Statistical Procedures
por: Huber, Peter J
Publicado: (1979)

NSF CBMS Conference on Geometric methods in mathematical physics
por: Kaiser, Gerald, et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_m3ffhn7ms0tdbusj7fdtp47ht6